Research ArticleClinical Studies
Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries
ANUSIYANTHAN ISAAC MARIAMPILLAI, JOSEPHINE PINEDA DELA CRUZ, JASON SUH, ABIRAMI SIVAPIRAGASAM, KYLE NEVINS and ALEXANDER A. HINDENBURG
Anticancer Research July 2017, 37 (7) 3649-3656;
ANUSIYANTHAN ISAAC MARIAMPILLAI
1Department of Hematology and Oncology, NYU Winthrop Hospital, Mineola, NY, U.S.A.
JOSEPHINE PINEDA DELA CRUZ
1Department of Hematology and Oncology, NYU Winthrop Hospital, Mineola, NY, U.S.A.
JASON SUH
2Department of Hematology and Oncology, Valley-Mount Sinai Comprehensive Cancer Care, Paramus, NJ, U.S.A.
ABIRAMI SIVAPIRAGASAM
3Department of Medicine, SUNY Upstate University Hospital, Syracuse, NY, U.S.A.
KYLE NEVINS
4Northwell Health Laboratories, New York, NY, U.S.A.
ALEXANDER A. HINDENBURG
1Department of Hematology and Oncology, NYU Winthrop Hospital, Mineola, NY, U.S.A.
In this issue
Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries
ANUSIYANTHAN ISAAC MARIAMPILLAI, JOSEPHINE PINEDA DELA CRUZ, JASON SUH, ABIRAMI SIVAPIRAGASAM, KYLE NEVINS, ALEXANDER A. HINDENBURG
Anticancer Research Jul 2017, 37 (7) 3649-3656;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.